| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |